They own 51% and will be acquiring 39% from their JV partner is what they’ve stated. Where’s the ambiguity?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025